These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy. Lee SU; Cho KH; Kim JH; Kim YS; Nam TK; Kim JS; Cho J; Choi SH; Shim SJ; Kim JH; Chang AR Technol Cancer Res Treat; 2021; 20():15330338211041212. PubMed ID: 34806469 [No Abstract] [Full Text] [Related]
4. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy. Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736 [TBL] [Abstract][Full Text] [Related]
5. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series. Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176 [TBL] [Abstract][Full Text] [Related]
6. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression. Lohm G; Neumann K; Budach V; Wiegel T; Hoecht S; Gollrad J Strahlenther Onkol; 2018 Apr; 194(4):325-332. PubMed ID: 29255924 [TBL] [Abstract][Full Text] [Related]
7. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N; Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502 [TBL] [Abstract][Full Text] [Related]
8. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice. Dal Pra A; Panje C; Zilli T; Arnold W; Brouwer K; Garcia H; Glatzer M; Gomez S; Herrera F; Kaouthar K; Papachristofilou A; Pesce G; Reuter C; Vees H; Zwahlen DR; Engeler D; Putora PM Strahlenther Onkol; 2018 Jan; 194(1):9-16. PubMed ID: 28656373 [TBL] [Abstract][Full Text] [Related]
9. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy. Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Sedlmayer F; Wenz F; Zips D; Wiegel T; Strahlenther Onkol; 2018 Jul; 194(7):619-626. PubMed ID: 29383406 [TBL] [Abstract][Full Text] [Related]
10. Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation. Baumann BC; Baumann JC; Christodouleas JP; Soffen E Brachytherapy; 2017; 16(2):291-298. PubMed ID: 28139422 [TBL] [Abstract][Full Text] [Related]
11. Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy. Rogowski P; Trapp C; von Bestenbostel R; Eze C; Ganswindt U; Li M; Unterrainer M; Zacherl MJ; Ilhan H; Beyer L; Kretschmer A; Bartenstein P; Stief C; Belka C; Schmidt-Hegemann NS Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1417-1428. PubMed ID: 34628521 [TBL] [Abstract][Full Text] [Related]
12. Salvage radiation therapy following radical prostatectomy. A national Danish study. Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Holmberg M; Sveistrup J; Meidahl Petersen P; Borre M Acta Oncol; 2016 May; 55(5):598-603. PubMed ID: 26399602 [TBL] [Abstract][Full Text] [Related]
13. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. Jang JW; Hwang WT; Guzzo TJ; Wein AJ; Haas NB; Both S; Vapiwala N Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1493-9. PubMed ID: 22401922 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. Lee EK; Mui WH; Chan AW; Tung Y; Wong FC Hong Kong Med J; 2018 Jun; 24(3):218-225. PubMed ID: 29807949 [TBL] [Abstract][Full Text] [Related]
15. Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study. Benziane-Ouaritini N; Zilli T; Giraud A; Ingrosso G; Di Staso M; Trippa F; Pommier P; Meyer E; Francolini G; Schick U; Pasquier D; Marc Cosset J; Magne N; Martin E; Gnep K; Renard-Penna R; Anger E; Achard V; Giraud N; Aristei C; Ferrari V; Pasquier C; Zaine H; Osman O; Detti B; Perennec T; Mihoci I; Supiot S; Latorzeff I; Sargos P Eur Urol Oncol; 2023 Aug; 6(4):390-398. PubMed ID: 37059627 [TBL] [Abstract][Full Text] [Related]
16. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy. Oehus AK; Kroeze SGC; Schmidt-Hegemann NS; Vogel MME; Kirste S; Becker J; Burger IA; Derlin T; Bartenstein P; Eiber M; Mix M; la Fougère C; Belka C; Combs SE; Grosu AL; Müller AC; Guckenberger M; Christiansen H; Henkenberens C BMC Cancer; 2020 Apr; 20(1):362. PubMed ID: 32349700 [TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation. Wahart A; Guy JB; Vallard A; Geissler B; Ben Mrad M; Falk AT; Prevot N; de Laroche G; Rancoule C; Chargari C; Magné N Br J Radiol; 2016; 89(1058):20150579. PubMed ID: 26648528 [TBL] [Abstract][Full Text] [Related]
19. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Choo R; Hruby G; Hong J; Bahk E; Hong E; Danjoux C; Morton G; DeBoer G Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):269-76. PubMed ID: 12023129 [TBL] [Abstract][Full Text] [Related]
20. Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy. Yoo S; You D; Kim YS; Hong JH; Ahn H; Kim CS Urol Int; 2017; 99(4):406-413. PubMed ID: 29020683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]